The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Open accessAbstract
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease is still rising. Therefore, new lines of medications are needed to treat the growing population of patients with cardiovascular disease. Although the majority of the existing pharmacotherapies for cardiovascular disease are synthesized molecules, natural compounds, such as resveratrol, are also being tested. Resveratrol is a non-flavonoid polyphenolic compound, which has several biological effects. Preclinical studies have provided convincing evidence that resveratrol has beneficial effects in animal models of hypertension, atherosclerosis, stroke, ischemic heart disease, arrhythmia, chemotherapy-induced cardiotoxicity, diabetic cardiomyopathy, and heart failure. Although not fully delineated, some of the beneficial cardiovascular effects of resveratrol are mediated through activation of silent information regulator 1 (SIRT1), AMP-activated protein kinase (AMPK), and endogenous anti-oxidant enzymes. In addition to these pathways, the anti-inflammatory, anti-platelet, insulin-sensitizing, and lipid-lowering properties of resveratrol contribute to its beneficial cardiovascular effects. Despite the promise of resveratrol as a treatment for numerous cardiovascular diseases, the clinical studies for resveratrol are still limited. In addition, several conflicting results from trials have been reported, which demonstrates the challenges that face the translation of the exciting preclinical findings to humans. Herein, we will review much of the preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular disease and provide information about the physiological and molecular signaling mechanisms involved. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, L., Wang, Y., Cui, M., Luo, W., Wang, X., Barber, P. A., & Chen, Z. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12162 · Cited by 58
RetractedAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658 · cited 1×
“Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a non-flavonoid polyphenolic compound belonging to the stilbenes group [3].”
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Mechanisms of plaque formation and rupture
Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000442015.53336.12 · Cited by 1,408
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.011 · Cited by 1,162
Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
Hadi, H. A. R., Carr, C. S., & Suwaidi, J. M. S. A. (2005) · PubMed Central · Cited by 1,079
Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
Devereux, R. B. (2004) · JAMA · doi:10.1001/jama.292.19.2350 · Cited by 881
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodriguez-Crespo, I., Witters, L. A., Power, D. A., Ortiz de Montellano, P. R., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 835
McMurray, J. J., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66621-4 · Cited by 831
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Gum, P. A., Kottke-Marchant, K., Poggio, E. D., Gurm, H., Welsh, P. A., Brooks, L., Sapp, S. K., & Topol, E. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01631-9 · Cited by 820
Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000316 · Cited by 678
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000029925.18593.5c · Cited by 666
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821daaf6 · Cited by 614
Ungvari, Z., Bagi, Z., Feher, A., Recchia, F. A., Sonntag, W. E., Pearson, K., de Cabo, R., & Csiszar, A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00260.2010 · Cited by 568
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Ann Forciea, M., Frishman, W. H., Jaigobin, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 514
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
Seddon, M., Looi, Y. H., & Shah, A. M. (2007) · Heart · doi:10.1136/hrt.2005.068270 · Cited by 479
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475
High-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455
Resveratrol induces mitochondrial biogenesis in endothelial cells
Csiszar, A., Labinskyy, N., Pinto, J. T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2009 · Cited by 449
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Resveratrol: French Paradox Revisited
Catalgol, B., Batirel, S., Taga, Y., & Ozer, N. K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00141 · Cited by 449
Calcium–calcineurin signaling in the regulation of cardiac hypertrophy
Wilkins, B. J., & Molkentin, J. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.121 · Cited by 440
Animal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Almeida, L., Vaz‐da‐Silva, M., Falcão, A., Soares, E., Costa, R., Loureiro, A. I., Fernandes‐Lopes, C., Rocha, J., Nunes, T., Wright, L., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800177 · Cited by 426
Leikert, J. F., Räthel, T. R., Wohlfart, P., Cheynier, V., Vollmar, A. M., & Dirsch, V. M. (2002) · Circulation · doi:10.1161/01.cir.0000034445.31543.43 · Cited by 424
Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415
Su, H.-C., Hung, L.-M., & Chen, J.-K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2005 · Cited by 412
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391
Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S.-I., Schechtman, K. B., Gu, C., Kunz, I., Fanelli, F. R., Patterson, B. W., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.015 · Cited by 380
Tomé-Carneiro, J., Larrosa, M., Yáñez-Gascón, M. J., Dávalos, A., Gil-Zamorano, J., Gonzálvez, M., García-Almagro, F. J., Ruiz Ros, J. A., Tomás-Barberán, F. A., Espín, J. C., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.011 · Cited by 378
Magyar, K., Halmosi, R., Palfi, A., Feher, G., Czopf, L., Fulop, A., Battyany, I., Sumegi, B., Toth, K., & Szabados, E. (2012) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2011-1424 · Cited by 364
Antiplatelet activity of synthetic and natural resveratrol in red wine.
Bertelli, A., Giovannini, L., Giannessi, D., MIGLIORI, M., Bernini, W., Fregoni, M., & Bertelli, A. A. A. (1995) · PubMed · Cited by 361
Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K., & Horio, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090266 · Cited by 358
Sundaresan, N. R., Pillai, V. B., Wolfgeher, D., Samant, S., Vasudevan, P., Parekh, V., Raghuraman, H., Cunningham, J. M., Gupta, M., & Gupta, M. P. (2011) · Science Signaling · doi:10.1126/scisignal.2001465 · Cited by 348
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
Chow, H.-H. S., Garland, L. L., Hsu, C.-H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., & Alberts, D. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0155 · Cited by 330
Štěrba, M., Popelová, O., Vávrová, A., Jirkovský, E., Kovaříková, P., Geršl, V., & Šimůnek, T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4795 · Cited by 329
Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., Storelli, C., Martines, G., De Caterina, R., & Carluccio, M. A. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.05.003 · Cited by 323
Liu, K., Zhou, R., Wang, B., & Mi, M.-T. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082024 · Cited by 323
Cooke, J. P., & Losordo, D. W. (2002) · Circulation · doi:10.1161/01.cir.0000014928.45119.73 · Cited by 302
Cardiovascular effects and molecular targets of resveratrol
Li, H., Xia, N., & Förstermann, U. (2012) · Nitric Oxide · doi:10.1016/j.niox.2011.12.006 · Cited by 287
Sulaiman, M., Matta, M. J., Sunderesan, N. R., Gupta, M. P., Periasamy, M., & Gupta, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00418.2009 · Cited by 287
Varga, Z. V., Giricz, Z., Liaudet, L., Haskó, G., Ferdinandy, P., & Pacher, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.030 · Cited by 286
Pilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.003 · Cited by 277
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
Calabrese, E. J., Mattson, M. P., & Calabrese, V. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110383625 · Cited by 273
Thirunavukkarasu, M., Penumathsa, S. V., Koneru, S., Juhasz, B., Zhan, L., Otani, H., Bagchi, D., Das, D. K., & Maulik, N. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.004 · Cited by 271
Brookins Danz, E. D., Skramsted, J., Henry, N., Bennett, J. A., & Keller, R. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.011 · Cited by 266
Jones, S. P., Girod, W. G., Palazzo, A. J., Granger, D. N., Grisham, M. B., Jourd’Heuil, D., Huang, P. L., & Lefer, D. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.5.h1567 · Cited by 265
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway
Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M. K., Gherghiceanu, M., Popescu, L. M., & Das, D. K. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp384 · Cited by 263
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., García-Conesa, M. T., Tomás-Barberán, F. A., & Espín, J. C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.030 · Cited by 259
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Movahed, A., Nabipour, I., Lieben Louis, X., Thandapilly, S. J., Yu, L., Kalantarhormozi, M., Rekabpour, S. J., & Netticadan, T. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/851267 · Cited by 257
Resveratrol: review on therapeutic potential and recent advances in drug delivery
Pangeni, R., Sahni, J. K., Ali, J., Sharma, S., & Baboota, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.919253 · Cited by 255
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
Cottart, C., Nivet‐Antoine, V., & Beaudeux, J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200589 · Cited by 250
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Self-citationEffects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro
Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y., & Wu, J. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.77 · Cited by 244
Kao, C.-L., Chen, L.-K., Chang, Y.-L., Yung, M.-C., Hsu, C.-C., Chen, Y.-C., Lo, W.-L., Chen, S.-J., Ku, H.-H., & Hwang, S.-J. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4333 · Cited by 244
Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
Gliemann, L., Schmidt, J. F., Olesen, J., Biensø, R. S., Peronard, S. L., Grandjean, S. U., Mortensen, S. P., Nyberg, M., Bangsbo, J., Pilegaard, H., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.258061 · Cited by 244
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., Tomás-Barberán, F. A., García-Conesa, M. T., & Espín, J. C. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6427-8 · Cited by 241
Ghanim, H., Sia, C. L., Abuaysheh, S., Korzeniewski, K., Patnaik, P., Marumganti, A., Chaudhuri, A., & Dandona, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0482 · Cited by 238
LI, Y., CAO, Z., & ZHU, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.08.002 · Cited by 235
Ren, J., Fan, C., Chen, N., Huang, J., & Yang, Q. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0561-8 · Cited by 232
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Dolinsky, V. W., Chan, A. Y. M., Robillard Frayne, I., Light, P. E., Des Rosiers, C., & Dyck, J. R. B. (2009) · Circulation · doi:10.1161/circulationaha.108.787440 · Cited by 232
Self-citationNagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J. K., Grazette, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23073 · Cited by 230
Cao, Z., & Li, Y. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.031 · Cited by 229
Resveratrol‐enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice
Wang, B., Yang, Q., Sun, Y., Xing, Y., Wang, Y., Lu, X., Bai, W., Liu, X., & Zhao, Y. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12312 · Cited by 228
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y.-H., Huang, H.-Y., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217
Zhang, C., Feng, Y., Qu, S., Wei, X., Zhu, H., Luo, Q., Liu, M., Chen, G., & Xiao, X. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr022 · Cited by 213
Resveratrol Improves Endothelial Function: Role of TNFα and Vascular Oxidative Stress
Zhang, H., Zhang, J., Ungvari, Z., & Zhang, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.187146 · Cited by 211
Tomé‐Carneiro, J., Gonzálvez, M., Larrosa, M., García‐Almagro, F. J., Avilés‐Plaza, F., Parra, S., Yáñez‐Gascón, M. J., Ruiz‐Ros, J. A., García‐Conesa, M. T., Tomás‐Barberán, F. A., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100673 · Cited by 209
Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats
Csiszar, A., Labinskyy, N., Olson, S., Pinto, J. T., Gupte, S., Wu, J. M., Hu, F., Ballabh, P., Podlutsky, A., Losonczy, G., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133397 · Cited by 209
Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury
Jones, S. P., Greer, J. J. M., Kakkar, A. K., Ware, P. D., Turnage, R. H., Hicks, M., van Haperen, R., de Crom, R., Kawashima, S., Yokoyama, M., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00129.2003 · Cited by 206
Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
Dolinsky, V. W., Chakrabarti, S., Pereira, T. J., Oka, T., Levasseur, J., Beker, D., Zordoky, B. N., Morton, J. S., Nagendran, J., Lopaschuk, G. D., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.018 · Cited by 206
Self-citationArunachalam, G., Yao, H., Sundar, I. K., Caito, S., & Rahman, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.080 · Cited by 205
Antioxidant Effects of Resveratrol in Cardiovascular, Cerebral and Metabolic Diseases
Carrizzo, A., Forte, M., Damato, A., Trimarco, V., Salzano, F., Bartolo, M., Maciag, A., Puca, A. A., & Vecchione, C. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.021 · Cited by 203
Bo, S., Ciccone, G., Castiglione, A., Gambino, R., De Michieli, F., Villois, P., Durazzo, M., Cavallo-Perin, P., & Cassader, M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320100009 · Cited by 202
Diabetes and Idiopathic Cardiomyopathy
Bertoni, A. G., Tsai, A., Kasper, E. K., & Brancati, F. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2791 · Cited by 201
Boocock, D. J., Patel, K. R., Faust, G. E. S., Normolle, D. P., Marczylo, T. H., Crowell, J. A., Brenner, D. E., Booth, T. D., Gescher, A., & Steward, W. P. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.017 · Cited by 200
The role of autophagy emerging in postinfarction cardiac remodelling
Kanamori, H., Takemura, G., Goto, K., Maruyama, R., Tsujimoto, A., Ogino, A., Takeyama, T., Kawaguchi, T., Watanabe, T., Fujiwara, T., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr073 · Cited by 200
KAGA, S., ZHAN, L., MATSUMOTO, M., & MAULIK, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.08.003 · Cited by 199
Bagul, P. K., Middela, H., Matapally, S., Padiya, R., Bastia, T., Madhusudana, K., Reddy, B. R., Chakravarty, S., & Banerjee, S. K. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.003 · Cited by 193
Sahebkar, A. (2013) · Nutrition Reviews · doi:10.1111/nure.12081 · Cited by 192
Patel, K. R., Andreadi, C., Britton, R. G., Horner-Glister, E., Karmokar, A., Sale, S., Brown, V. A., Brenner, D. E., Singh, R., Steward, W. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005870 · Cited by 190
Singh, N., Agrawal, M., & Doré, S. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400094w · Cited by 183
Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
Basly, J.-P., Marre-Fournier, F., Le Bail, J.-C., Habrioux, G., & Chulia, A. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00650-5 · Cited by 179
Hung, L.-M., Su, M.-J., & Chen, J.-K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.016 · Cited by 178
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions
Camont, L., Cottart, C.-H., Rhayem, Y., Nivet-Antoine, V., Djelidi, R., Collin, F., Beaudeux, J.-L., & Bonnefont-Rousselot, D. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.12.003 · Cited by 176
Penumathsa, S. V., Thirunavukkarasu, M., Koneru, S., Juhasz, B., Zhan, L., Pant, R., Menon, V. P., Otani, H., & Maulik, N. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.10.018 · Cited by 176
Penumathsa, S. V., Thirunavukkarasu, M., Zhan, L., Maulik, G., Menon, V. P., Bagchi, D., & Maulik, N. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00251.x · Cited by 175
Hausenblas, H. A., Schoulda, J. A., & Smoliga, J. M. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400173 · Cited by 174
Csiszar, A., Sosnowska, D., Wang, M., Lakatta, E. G., Sonntag, W. E., & Ungvari, Z. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr228 · Cited by 174
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
Ahn, J., Cho, I., Kim, S., Kwon, D., & Ha, T. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.012 · Cited by 173
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.06.001 · Cited by 173
Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium
Ferrero, M. E., Bertelli, A. A., Fulgenzi, A., Pellegatta, F., Corsi, M. M., Bonfrate, M., Ferrara, F., Caterina, R. D., Giovannini, L., & Bertelli, A. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1208 · Cited by 173
Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D., & Netticadan, T. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.228 · Cited by 172
Block, G., Jensen, C. D., Norkus, E. P., Dalvi, T. B., Wong, L. G., McManus, J. F., & Hudes, M. L. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-30 · Cited by 170
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia
Whelton, P. K., He, J., & Muntner, P. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001701 · Cited by 170
Bhatt, S. R., Lokhandwala, M. F., & Banday, A. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.026 · Cited by 169
Resveratrol Levels and All-Cause Mortality in Older Community-Dwelling Adults
Semba, R. D., Ferrucci, L., Bartali, B., Urpí-Sarda, M., Zamora-Ros, R., Sun, K., Cherubini, A., Bandinelli, S., & Andres-Lacueva, C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1582 · Cited by 168
Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P., & Kennedy, D. O. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000737 · Cited by 168
Calorie restriction and resveratrol in cardiovascular health and disease
Dolinsky, V. W., & Dyck, J. R. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.010 · Cited by 168
Self-citationResveratrol: a cardioprotective substance
Wu, J. M., & Hsieh, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05854.x · Cited by 167
Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia
Huang, S. S., Tsai, M. C., Chih, C. L., Hung, L. M., & Tsai, S. K. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01195-x · Cited by 167
Tatlıdede, E., Şehırlı, Ö., Velioğlu‐Öğünç, A., Çetınel, Ş., Yeğen, B. Ç., Yarat, A., Süleymanoğlu, S., & Şener, G. (2009) · Free Radical Research · doi:10.1080/10715760802673008 · Cited by 164
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
McKinsey, T. A., & Kass, D. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2193 · Cited by 163
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults
Wong, R. H. X., Berry, N. M., Coates, A. M., Buckley, J. D., Bryan, J., Kunz, I., & Howe, P. R. C. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362b9d6 · Cited by 162
Berrougui, H., Grenier, G., Loued, S., Drouin, G., & Khalil, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.017 · Cited by 161
Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials
Liu, Y., Ma, W., Zhang, P., He, S., & Huang, D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.03.009 · Cited by 161
Militaru, C., Donoiu, I., Craciun, A., Scorei, I. D., Bulearca, A. M., & Scorei, R. I. (2013) · Nutrition · doi:10.1016/j.nut.2012.07.006 · Cited by 161
Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., Takeyama, T., Kawaguchi, T., Watanabe, T., Morishita, K., Kawasaki, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.009 · Cited by 157
Bertrand, L., Ginion, A., Beauloye, C., Hebert, A. D., Guigas, B., Hue, L., & Vanoverschelde, J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01269.2005 · Cited by 156
Rimbaud, S., Ruiz, M., Piquereau, J., Matéo, P., Fortin, D., Veksler, V., Garnier, A., & Ventura‐Clapier, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026391 · Cited by 154
Wang, Z., Zou, J., Cao, K., Hsieh, T., Huang, Y., & WU, J. M. (2005) · PubMed · Cited by 152
Miatello, R. M., VAZQUEZ, M., Renna, N. F., Cruzado, M., Zumino, A. Z. P., & Risler, N. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.12.012 · Cited by 152
Xu, X., Chen, K., Kobayashi, S., Timm, D. J., & Liang, Q. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189589 · Cited by 151
Cardiac hypertrophy: A matter of translation
Hannan, R. D., Jenkins, A., Jenkins, A., & Brandenburger, Y. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03873.x · Cited by 150
Resistant Hypertension: A Review of Diagnosis and Management
Vongpatanasin, W. (2014) · JAMA · doi:10.1001/jama.2014.5180 · Cited by 146
Carrizzo, A., Puca, A. A., Damato, A., Marino, M., Franco, E., Pompeo, F., Traficante, A., Civitillo, F., Santini, L., Trimarco, V., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.01009 · Cited by 145
Role of AMP-activated protein kinase in healthy and diseased hearts
Dolinsky, V. W., & Dyck, J. R. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00329.2006 · Cited by 145
Self-citationShen, M., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D., & Sheu, J. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06788.x · Cited by 143
Rocha, K. K. R., Souza, G. A., Ebaid, G., Seiva, F. R. F., Cataneo, A. C., & Novelli, E. L. B. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.03.010 · Cited by 143
Metabolites and tissue distribution of resveratrol in the pig
Azorín‐Ortuño, M., Yáñez-Gascón, M. J., Vallejo, F., Pallarés, F. J., Larrosa, M., Lucas, R., Morales, J. C., Tomás-Barberán, F. A., García‐Conesa, M., & Espín, J. C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100140 · Cited by 143
Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells
Hwang, J., Kwon, D. Y., Park, O. J., & Kim, M. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0069-7 · Cited by 141
Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy
Sundaresan, N. R., Pillai, V. B., & Gupta, M. P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.008 · Cited by 139
Dolinsky, V. W., Rogan, K. J., Sung, M. M., Zordoky, B. N., Haykowsky, M. J., Young, M. E., Jones, L. W., & Dyck, J. R. B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00044.2013 · Cited by 133
Self-citationGanapathy, S., Chen, Q., Singh, K. P., Shankar, S., & Srivastava, R. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015627 · Cited by 133
Do, G.-M., Kwon, E.-Y., Kim, H., Jeon, S.-M., Ha, T. Y., Park, T., & Choi, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.113 · Cited by 132
Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters.
Cho, I.-J., Ahn, J., Kim, S., Choi, M.-S., & Ha, T. (2008) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2007.12.140 · Cited by 130
Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., & Das, D. K. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.09.028 · Cited by 129
Fukuda, S., Kaga, S., Zhan, L., et al. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:043 · Cited by 129
Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A. A. E., de Jonge, R., Beemster, P. W. T., & de Jong, J. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01441-9 · Cited by 129
Li, H., Yin, R., Chen, D., Liu, D., Wang, D., Yang, Q., & Dong, Y. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21197 · Cited by 127
Balteau, M., Steenbergen, A. V., Timmermans, A. D., Dessy, C., Behets-Wydemans, G., Tajeddine, N., Castanares‐Zapatero, D., Gilon, P., Vanoverschelde, J., Horman, S., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00210.2014 · Cited by 125
Arafa, M. H., Mohammad, N. S., Atteia, H. H., & Abdel‐Aziz, H. R. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0339-y · Cited by 125
MIZUTANI, K., Ikeda, K., Kawai, Y., & Yamori, Y. (2000) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.46.78 · Cited by 125
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure
Gu, X. S., Wang, Z., Ye, Z., Lei, J., Li, L., Su, D., & Zheng, X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.january.17.17 · Cited by 125
Zhang, H., Morgan, B., Potter, B. J., Ma, L., Dellsperger, K. C., Ungvari, Z. I., & Zhang, C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00489.2010 · Cited by 122
Drug discovery for heart failure: a new era or the end of the pipeline?
Kaye, D. M., & Krum, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2219 · Cited by 121
Park, D., Baek, K., Kim, J.-R., Lee, J. J., Ryu, S.-H., Chin, B.-R., & Baek, S. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.3.020 · Cited by 121
Voloshyna, I., Hai, O. Y., Littlefield, M. J., Carsons, S. E., & Reiss, A. B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.08.024 · Cited by 120
Zou, J., Wang, Z., Huang, Y., Cao, K., & WU, J. M. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.3.317 · Cited by 119
Wang, S., Song, P., & Zou, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315812 · Cited by 119
Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example
Smoliga, J. M., Vang, O., & Baur, J. A. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr062 · Cited by 119
Potential of resveratrol in the treatment of heart failure
Raj, P., Louis, X. L., Thandapilly, S. J., Movahed, A., Zieroth, S. R., & Netticadan, T. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.011 · Cited by 118
Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits
Wilson, T. E., Knight, T. J., Beitz, D. C., Lewis, D. S., & Engen, R. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00260-3 · Cited by 117
Rush, J. W. E., Quadrilatero, J., Levy, A. S., & Ford, R. J. (2007) · Experimental Biology and Medicine · doi:10.3181/00379727-232-2320814 · Cited by 116
Ishrat, T., Mohamed, I., Pillai, B. A., Soliman, S. M., Fouda, A. Y., Ergul, A., El‐Remessy, A. B., & Fagan, S. C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8766-x · Cited by 116
Resveratrol protects against arsenic trioxide‐induced cardiotoxicity in vitro and in vivo
Zhao, X., Li, G.-Z., Liu, Y., Chai, L., Chen, J., Zhang, Y., Du, Z., Lu, Y., & Yang, B. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.81 · Cited by 116
Juric, D., Wojciechowski, P. W., Das, D. K., & Netticadan, T. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00852.2006 · Cited by 115
Robich, M. P., Osipov, R. M., Nezafat, R., Feng, J., Clements, R., Bianchi, C. F., Boodhwani, M., Coady, M. A., Laham, R. J., & Sellke, F. W. (2010) · Circulation · doi:10.1161/circulationaha.109.920132 · Cited by 112
Balteau, M., Tajeddine, N., de Meester, C., Ginion, A., Rosiers, C. D., Brady, N. R., Sommereyns, C., Horman, S., Vanoverschelde, J., Gailly, P. L., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr230 · Cited by 112
Aubin, M.-C., Lajoie, C., Clément, R., Gosselin, H., Calderone, A., & Perrault, L. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135061 · Cited by 112
Chow, S., Hshu, Y.-C., Wang, J., & Chen, J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00881.2006 · Cited by 111
Mikulski, D., Górniak, R., & Molski, M. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.11.044 · Cited by 109
Elrod, J. W., Greer, J. J. M., Bryan, N. S., Langston, W., Szot, J. F., Gebregzlabher, H., Janssens, S. P., Feelisch, M., & Lefer, D. J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000224324.52466.e6 · Cited by 108
Mechanisms of resveratrol-induced platelet apoptosis
Lin, K., Hsiao, G., Shih, C.-M., Chou, D., & Sheu, J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp139 · Cited by 108
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells
de Brito, P. M., Devillard, R., Nègre‐Salvayre, A., Almeida, L. M., Dinis, T. C. P., Salvayre, R., & Augè, N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.011 · Cited by 107
Li, Z., Pang, L., Fang, F., Zhang, G., Zhang, J. C., Xie, M., & Wang, L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.019 · Cited by 106
The Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 106
Rezk, Y. A., Balulad, S. S., Keller, R. S., & Bennett, J. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.11.030 · Cited by 105
Kang, W., Hong, H. J., Guan, J., Kim, D. G., Yang, E.-J., Koh, G., Park, D.-B., Han, C. H., Lee, Y. J., & Lee, D.-H. (2011) · Metabolism · doi:10.1016/j.metabol.2011.08.003 · Cited by 104
Resveratrol: Challenges in Translation to the Clinic — A Critical Discussion
Subramanian, L., Youssef, S., Bhattacharya, S., Kenealey, J., Polans, A. S., & van Ginkel, P. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1486 · Cited by 103
Anti-atherogenic effects of resveratrol
Ramprasath, V. R., & Jones, P. J. H. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.77 · Cited by 103
Dash, S., Xiao, C., Morgantini, C., Szeto, L., & Lewis, G. F. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302342 · Cited by 102
Stef, G., Csiszár, A., Lerea, K. M., Ungvari, Z. I., & Veress, G. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000238592.67191.ab · Cited by 101
Chen, F., Qian, L., Deng, B., Liu, Z., Zhao, Y., & Le, Y. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12131 · Cited by 101
Olas, B., Wachowicz, B., Saluk, J., & Zieliński, T. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00273-6 · Cited by 100
Buttari, B., Profumo, E., Segoni, L., D’Arcangelo, D., Rossi, S., Facchiano, F., Saso, L., Businaro, R., Iuliano, L., & Riganò, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/257543 · Cited by 99
Thompson, A. M., Martin, K. A., & Rzucidlo, E. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085495 · Cited by 98
Franco, J. G., Lisboa, P. C., Lima, N. S., Amaral, T. A. S., Peixoto‐Silva, N., Resende, Â. C., OLIVEIRA, E. B. D., Passos, M. C. F., & de Moura, E. G. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.019 · Cited by 97
Biala, A., Tauriainen, E., Siltanen, A., Shi, J., Merasto, S., Louhelainen, M., Martonen, E., Finckenberg, P., Muller, D. N., & Mervaala, E. (2010) · Blood Pressure · doi:10.3109/08037051.2010.481808 · Cited by 97
Up-regulation of Adiponectin by Resveratrol
Wang, A., Liu, M., Liu, X., Dong, L., Glickman, R. D., Slaga, T. J., Zhou, Z., & Liu, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188144 · Cited by 96
Tomé‐Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García‐Almagro, F. J., Ruiz‐Ros, J. A., Tomás-Barberán, F. A., García‐Conesa, M., & Espín, J. C. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12150 · Cited by 95
Anton, S. D., Embry, C., Marsiske, M., Lu, X., Doss, H., Leeuwenburgh, C., & Manini, T. M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.015 · Cited by 95
Differential response to myocardial reperfusion injury in eNOS-deficient mice
Sharp, B. R., Jones, S. P., Rimmer, D. M., & Lefer, D. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00855.2001 · Cited by 95
Cheng, Y., Di, S., Fan, C., Cai, L., Gao, C., Jiang, P., Hu, W., Ma, Z., Jiang, S., Dong, Y., et al. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1258-x · Cited by 95
Calcium Fructoborate—Potential Anti-inflammatory Agent
Scorei, I. R., & Rotaru, P. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-8972-6 · Cited by 94
Guo, R., Li, W., Liu, B., Li, S., Zhang, B., & Xu, Y. (2014) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.890858 · Cited by 93
Cheng, P., Ho, W., Su, Y., Lu, P., Chen, B., Cheng, W., Lu, W., Sun, G., Yeh, T., Hsiao, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12648 · Cited by 92
Al-Abd, A. M., Mahmoud, A. M., El-Sherbiny, G. A., El‐Moselhy, M. A., Nofal, S. M., El-Latif, H. A. A., El‐Eraky, W. I., & El‐Shemy, H. A. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00783.x · Cited by 90
Resveratrol and the eye: activity and molecular mechanisms
Bola, C., Bartlett, H. E., & Eperjesi, F. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2604-8 · Cited by 89
Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by Resveratrol
Liu, J., Chen, J., Chan, P., Cheng, C., & Cheng, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000103162.76220.51 · Cited by 89
Novaković, A., Gojković‐Bukarica, L., Peric, M. S., Nezic, D., Djukanovic, B. P., Markovic‐Lipkovski, J., & Heinle, H. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050863 · Cited by 89
Cited by
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Ali, M. Y., Sina, A. A. I., Khandker, S. S., Neesa, L., Tanvir, E. M., Kabir, A., Khalil, M. I., & Gan, S. H. (2020) · Foods · doi:10.3390/foods10010045 · Cited by 504
Resveratrol and Cardiovascular Diseases
Bonnefont-Rousselot, D. (2016) · Nutrients · doi:10.3390/nu8050250 · Cited by 442
Biological Activities of Stilbenoids
Akinwumi, B., Bordun, K.-A., & Anderson, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030792 · Cited by 373
Metadata
- Authors
- Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 1852
- Issue
- 6
- Pages
- 1155-1177
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1994643898
- Cited by
- 335
- References
- 294
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.